10 November 2021 | News
Around 5000 people from the top 10 cities of India took the test
Image credit: Shutterstock
Mumbai-based startup Fitterfly Healthtech pioneered the #FightPrediabetes campaign, in partnership with top doctors of India, Roche Diabetes, USV and Lal Path labs, kickstarted a campaign on August 14, 90 days before the diabetes day, to draw attention to the prediabetes situation in India.
As part of this campaign, a nationwide study was conducted to assess the risk of prediabetes in Indian adults, the first-of-its-kind initiative in India.
The test is an evidence-based, clinically-validated tool for assessing an individual’s risk of Pre-diabetes, following international protocols for prediabetes detection such as American Diabetes Association and Centers for Disease Control (USA).
Around 5000 people from the top 10 cities of India took the test and people were asked questions about their health profile, family history of diabetes, other health conditions and lifestyle.
The data was then studied using statistical analysis for the calculation of relative risk of prediabetes with factors like age, BMI, physical activity, family history of diabetes and the presence of high blood pressure.
Summary points: